Balbuena, Roxan .

HRN: 13-57-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2024
AMPICILLIN 1GM (VIAL)
04/15/2024
04/15/2024
IV
2g
Q6
PROM X 3 Hours
Waiting Final Action 
04/15/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/15/2024
04/15/2024
IV
500mg
Q8hrs
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action 
04/17/2024
METRONIDAZOLE 500MG (TAB)
04/17/2024
04/23/2024
PO
500mg
Tid
Sp Ltcs
Waiting Final Action 
04/17/2024
CEFUROXIME 1.5GM (VIAL)
04/17/2024
04/18/2024
IV
1.5gm
3 Doses Q8
Sp Ltcs
Waiting Final Action 
04/17/2024
CEFUROXIME 500MG (TAB)
04/17/2024
04/23/2024
PO
500mg
Bid
Sp Ltcs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: